Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ochratoxin A: the continuing enigma.

Evelyn O'Brien1, Daniel R Dietrich

  • 1Environmental Toxicology, University of Konstanz, Germany. evelyn.obrien@uni-konstanz.de

Critical Reviews in Toxicology
|March 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States.

NAM journal·2026
Same author

Species, cell proliferation state and oxygen partial pressure are major factors in the in vitro toxicity of repurposed potential ADPKD drugs in human and murine renal proximal tubule cells.

Archives of toxicology·2026
Same author

Identification of drug repurposing candidates for the treatment of polycystic kidney disease.

British journal of pharmacology·2026
Same author

The alarming consequences of workforce reductions at the FDA, EPA, NIH and CDC in the United States.

Archives of toxicology·2025
Same author

The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States.

Toxicology·2025
Same author

The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States.

Environmental toxicology and pharmacology·2025
Same journal

Microplastic trafficking in maternal-fetal system: a systematic review and quantitative profiling linking particle characteristics to developmental biology.

Critical reviews in toxicology·2026
Same journal

Addendum.

Critical reviews in toxicology·2026
Same journal

Inhalation exposure and health effects of copper particles in the context of occupational exposure limit derivation.

Critical reviews in toxicology·2026
Same journal

Screening for the ovarian toxicity of industrial chemicals - ovarian follicles and corpora lutea counts in rats, an inter- and intra-laboratory comparison.

Critical reviews in toxicology·2026
Same journal

Evaluation of the modes of action for key noncancer effects of 1,3-Butadiene: input from an independent expert panel to support derivation of data-derived extrapolation factors.

Critical reviews in toxicology·2026
Same journal

The effect of antioxidants on antineoplastic-induced male reproductive system damage: a systematic review of experimental studies.

Critical reviews in toxicology·2026
See all related articles

Ochratoxin A (OTA) is a mycotoxin causing various diseases in animals and humans. Understanding its toxicity mechanisms and species-specific effects is crucial for setting safe food limits.

Area of Science:

  • Toxicology
  • Food Safety
  • Mycotoxicology

Background:

  • Ochratoxin A (OTA) is a mycotoxin linked to numerous diseases in animals and humans, including nephropathies and urothelial tumors.
  • OTA exhibits nephrotoxic, carcinogenic, teratogenic, immunotoxic, and hepatotoxic effects, prompting international agencies to establish safe dietary limits.
  • The precise mechanisms of OTA toxicity, whether genotoxic or epigenetic, remain unclear, with proposed pathways including apoptosis induction, mitochondrial dysfunction, and DNA adduct formation.

Purpose of the Study:

  • To review and discuss current data on Ochratoxin A-mediated toxicity.
  • To focus on the relevance of existing data for in vivo situations.
  • To propose future research strategies for understanding OTA toxicity.

Main Methods:

Related Experiment Videos

  • Literature review and data collation on Ochratoxin A toxicity.
  • Analysis of mechanistic and epidemiological studies.
  • Discussion of in vivo and in vitro model system relevance.

    • Main Results:

    • OTA toxicity is characterized by significant species- and sex-specific differences.
    • A strict structure-activity relationship influences OTA's toxic effects.
    • The predominant mechanism of OTA toxicity (genotoxic vs. epigenetic) requires further elucidation.

    Conclusions:

    • Accurate risk assessment for OTA requires understanding its complex toxicity mechanisms and species-specific variations.
    • Appropriate in vivo and in vitro models are essential for generating reliable data on OTA toxicity.
    • Further research is needed to fully understand and mitigate the risks associated with Ochratoxin A exposure.